| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
days
| 6 |
7.1 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
5 |
days |
98849 |
2160 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98.0 days
| 8 |
7.0 |
mm |
0.2 |
0.57 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99235 |
2278 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98.0 days
| 7 |
7.6 |
mm |
0.1 |
0.26 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99345 |
2278 |
| WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
12 |
8.3 |
mm |
0.2 |
0.69 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
100339 |
2460 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175.0 days
| 10 |
9.0 |
mm |
0.1 |
0.32 |
echocardiography |
0.0 |
sham ACF |
105 |
days |
99237 |
2278 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72.0 days
| 5 |
6.9 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
99339 |
2278 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72.0 days
| 5 |
7.0 |
mm |
0.1 |
0.22 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
99341 |
2278 |
| WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
5 |
7.9 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
100306 |
2460 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
days
| 6 |
7.2 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
360 |
min |
98843 |
2160 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
days
| 6 |
7.3 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
720 |
min |
98845 |
2160 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
days
| 6 |
7.1 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
98847 |
2160 |
| SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98.0 days
| 7 |
7.7 |
mm |
0.2 |
0.53 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99343 |
2278 |